Pfizer Inc PFE:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 5:45 PM EST

50.24UNCH (UNCH)

Volume

789,315

50.24

+0.53 (+1.07%)

Volume

15,109,339

52 week range

41.44 - 61.71

Open49.75
Day High51.15
Day Low49.75
Prev Close49.71
52 Week High61.71
52 Week High Date12/20/21
52 Week Low41.44
52 Week Low Date10/11/22

Key Stats

Market Cap282.013B
Shares Out5.61B
10 Day Average Volume18.75M
Dividend1.60
Dividend Yield3.18%
Beta0.69
YTD % Change-14.92

KEY STATS

Open49.75
Day High51.15
Day Low49.75
Prev Close49.71
52 Week High61.71
52 Week High Date12/20/21
52 Week Low41.44
52 Week Low Date10/11/22
Market Cap282.013B
Shares Out5.61B
10 Day Average Volume18.75M
Dividend1.60
Dividend Yield3.18%
Beta0.69
YTD % Change-14.92

RATIOS/PROFITABILITY

EPS (TTM)5.27
P/E (TTM)9.53
Fwd P/E (NTM)10.06
EBITDA (TTM)42.501B
ROE (TTM)35.91%
Revenue (TTM)99.676B
Gross Margin (TTM)65.51%
Net Margin (TTM)30.35%
Debt To Equity (MRQ)39.59%

EVENTS

Earnings Date02/06/2023(est)
Ex Div Date11/03/2022
Div Amount0.40
Split Date-
Split Factor-

Latest On Pfizer Inc

FDA expected to decide on Pfizer RSV vaccine for older adults by May 20239 Hours AgoCNBC.com
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting historyDecember 6, 2022CNBC.com
These resilient stocks that keep expanding margins are Goldman's picks for 2023December 2, 2022CNBC.com
Final Trades: PFE, FLEX, SMH & FLNovember 18, 2022CNBC.com
Credit Suisse calls this group the ultimate 'refuge from stormy seas'November 18, 2022CNBC.com

Content From Our Affiliates

Credit Suisse Remains a Buy on Pfizer (PFE)December 6, 2022TipRanks
Positive Report for Pfizer (PFE) from Credit SuisseNovember 23, 2022TipRanks
BioNTech, Pfizer present new data on Omicron BA.4/BA.5-adapted bivalent boosterNovember 18, 2022TipRanks
Pfizer initiated with an Outperform at Credit SuisseNovember 17, 2022TipRanks
Lucira Health announces national launch of Lucira connect test-to-treat serviceNovember 17, 2022TipRanks

Profile

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global...

Albert Bourla Ph.D.

Chairman of the Board, Chief Executive Officer

David Denton

Executive Vice President, Chief Financial Officer

Aamir Malik

Executive Vice President, Chief Business Innovation Officer

Lidia Fonseca Ph.D.

Executive Vice President, Chief Digital and Technology Officer

Douglas Lankler

Executive Vice President, General Counsel

Address

235 E 42ND ST

New York, NY

10017-5703

United States

https://www.pfizer.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
MRK Merck & Co Inc	110.09	+1.16	+1.06%
ABBV Abbvie Inc	165.40	+1.68	+1.03%
RHHBY Roche Holding AG	39.95	-0.32	-0.79%
JNJ